We file Ranitidine cancer lawsuits for heartburn patients diagnosed with digestive tract cancer. Ranitidine cancer lawyers and the U.S. Food and Drug Administration (FDA) have cited a probably cancer link in Ranitidine, a primary ingredient in Zantac and other Over the Counter antacid medicines.
In addition, accompanying these revelations was the removal or recall of Zantac from drugstore shelves. Numerous retail stores halted the sale of Zantac, including Walgreens and CVS Pharmacy. However, court litigation is the formal legal method through which plaintiffs can prove their case.
Ranitidine Cancer Lawsuits Against Zantac Manufacturer
Call Now: (888) 510-9256
Thousands of cancer victims are coming forward to file Ranitidine cancer lawsuits against the manufacturer of a variety of heartburn drugs. A subsidiary of the Novartis company with international reach is the manufacturer of Zantac. However, there are many generic manufacturers as well. As such, in brand name and generic form, the drug has been used by tens of millions of people across the Unites States.
Generic Ranitidine Cancer Lawyers file Intestinal Injury Claims
Ranitidine is the active ingredient in Zantac GERD medication. However, it has also been used in generic form and in other brand name antacid medicines.
Many heartburn patients treat their condition with a variety of Over the Counter indigestion drugs.
If you or a loved one were diagnosed with any digestive tract, intestinal or other cancer after use of heartburn medication, you may be entitled to compensation.
Click here for additional information on our Zantac lawsuit attorneys.
Harvard Medical School Publication Reviews Zantac Carcinogen
A recent publication by Harvard Medical School discusses the role of the carcinogen NDMA in Ranitidine cancer lawsuits. Nevertheless, pharmaceutical defense attorneys deny the cancer link. To view information in a relevant Harvard Medical School review, click here.
Contact our Ranitidine cancer lawyers for a free case review.
